The Structural Biology Core will be a shared central resource to enable researchers at the University of Pennsylvania to bring molecular and structural analysis and understanding to their research projects on AIDS- related macromolecules. Molecular mechanism, molecular structure and drug design all are subjects of currently funded research at the University. They also are common themes in several upcoming projects. A common need in these projects as well as those on the biology of AIDS-related macromolecules is to enable the use of structural biology approaches in order to learn more about structure and mechanism and to use that information for structure- and mechanism-based antagonist design. The goal of the Structural Biology Core will be to provide services which facilitate the use of structural biology to solve AIDS-related research problems. The four main functions of the Structural Biology Core will be: (1) Protein Production, including scaled up expression and purification to provide materials for structural and mechanistic studies; (2) Interaction Analysis, focusing on optical biosensor analysis of macromolecular interaction kinetics and characterization of assembly mechanisms in HIV-1 and the pathogenesis of AIDS; (3) Structure-Function Analysis, including molecular graphics visualization of high resolution structures and structural guidance for mutagenic analysis; and (4) Resource Networking, in particular guiding users to technology resources beyond the Core for specialized biophysical, computational and high resolution structure determination. A key strength of the CFAR at the University of Pennsylvania will be to bring together researchers investigating the biology and chemistry of immunodeficiency viruses and AIDS with the resources to elucidate molecular and structural properties and to use these properties as lead information in drug design. Coordinated research and collaborations will be encouraged amongst biologists, chemists and structural biologists. The Structure Biology Core will provide a centralized resource which will provide protein materials, initiate interaction analyses and structure-function studies, facilitate and lead AIDS-related projects into the structural biology area and hence help meet the molecular, structural and drug design goals of AIDS research at UPenn.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
1P30AI045008-01
Application #
6167476
Study Section
Project Start
1999-07-01
Project End
2000-06-30
Budget Start
Budget End
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Venuto, Charles S; Lim, Jihoon; Messing, Susan et al. (2018) Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s. Antivir Ther 23:345-351
Clarke, Erik L; Lauder, Abigail P; Hofstaedter, Casey E et al. (2018) Microbial Lineages in Sarcoidosis. A Metagenomic Analysis Tailored for Low-Microbial Content Samples. Am J Respir Crit Care Med 197:225-234
Barbian, Hannah J; Connell, Andrew Jesse; Avitto, Alexa N et al. (2018) CHIIMP: An automated high-throughput microsatellite genotyping platform reveals greater allelic diversity in wild chimpanzees. Ecol Evol 8:7946-7963
Meyers, Kathrine; Rodriguez, Kristina; Brill, Atrina L et al. (2018) Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants. AIDS Behav 22:1209-1216
Abdel-Mohsen, Mohamed; Kuri-Cervantes, Leticia; Grau-Exposito, Judith et al. (2018) CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Sci Transl Med 10:
Barbian, Hannah J; Li, Yingying; Ramirez, Miguel et al. (2018) Destabilization of the gut microbiome marks the end-stage of simian immunodeficiency virus infection in wild chimpanzees. Am J Primatol 80:
Ke, Ruian; Li, Hui; Wang, Shuyi et al. (2018) Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence. Proc Natl Acad Sci U S A 115:E7139-E7148
Park, Yoon-Dong; Jarvis, Joseph N; Hu, Guowu et al. (2018) Transcriptional Profiling of Patient Isolates Identifies a Novel TOR/Starvation Regulatory Pathway in Cryptococcal Virulence. MBio 9:
MacBrayne, Christine E; Marks, Kristen M; Fierer, Daniel S et al. (2018) Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate. J Antimicrob Chemother 73:2112-2119
Veenhuis, Rebecca T; Kwaa, Abena K; Garliss, Caroline C et al. (2018) Long-term remission despite clonal expansion of replication-competent HIV-1 isolates. JCI Insight 3:

Showing the most recent 10 out of 775 publications